In order to further explore the KRAS mutation-related mRNAs and lncRNAs in PAAD, the differential expressions of lncRNAs and mRNAs between patients of the KRAS-mutant group and those of the KRAS-wildtype group were analyzed. The gene discussed is KRAS; the disease is pancreatic adenocarcinoma.